NCT03591497

Brief Summary

Balance of the body is achieved by the coordination of three major systems, visual, vestibular and proprioceptive sensation and by the reflexive control of the limbs. In myelopathy, factors like balance and posture, range of motion, muscle strength, coordinated motor control, muscle tone and proprioception are affected. Balance and gait rehabilitation is an important goal in myelopathy. Virtual reality (VR) is a computer based technology that is used for task oriented biofeedback therapy in rehabilitation. This study was envisioned to observe the utility of VR in rehabilitation for improving balance in patients of myelopathy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2018

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

June 20, 2018

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 19, 2018

Completed
Last Updated

July 19, 2018

Status Verified

July 1, 2018

Enrollment Period

4 months

First QC Date

June 20, 2018

Last Update Submit

July 7, 2018

Conditions

Keywords

MyelopathyVirtual RealityRehabilitationBalance

Outcome Measures

Primary Outcomes (3)

  • Change in Berg Balance Scale (BBS)

    Scale is used to measure balance during functional activities. It is a 14 item scale. A 5 point scale is used for each item (0-4). "0" indicates the lowest level of function and "4" the highest level of function. Total Score = 56. Total score is obtained by adding the individual scores.

    At admission and at discharge from hospital or 24 weeks, whichever is earlier.

  • Change in Tinetti performance oriented mobility assessment (POMA)

    Balance section of Tinetti Performance Oriented Mobility Assessment (Tinetti Performance Oriented Mobility Assessment has two subscales, Balance and Gait section.) Balance section has 9 items. Each item can be scored in a 3 point ordinal scale (0-2). "0" indicates the lowest level of function and "2" the highest level of function. Total Score = 16. Total score is obtained by adding the individual scores.

    At admission and at discharge from hospital or 24 weeks, whichever is earlier.

  • Change in Functional reach test (forward and lateral)

    Functional reach score. It is used to measure postural stability and dynamic balance in sitting position. It has three subsections. Right lateral reach, left lateral reach and forward lateral reach. The value of each is obtained by measuring the distance in centimeter. The total score is obtained by adding the scores of the three subsections. Lower value indicates the lower level of function and higher value the higher level of function.

    At admission and at discharge from hospital or 24 weeks, whichever is earlier.

Secondary Outcomes (6)

  • Difference in Berg Balance Scale (BBS) between groups

    At admission and at discharge from hospital or 24 weeks, whichever is earlier.

  • Difference in Tinetti performance oriented mobility assessment (POMA) between groups

    At admission and at discharge from hospital or 24 weeks, whichever is earlier.

  • Difference in Functional reach test (forward and lateral) between groups

    At admission and at discharge from hospital or 24 weeks, whichever is earlier.

  • Difference in Hospital anxiety and depression scale (HADS) between groups

    At admission and at discharge from hospital or 24 weeks, whichever is earlier.

  • Difference in Spinal cord independence measurement scale (SCIM) between groups

    At admission and at discharge from hospital or 24 weeks, whichever is earlier.

  • +1 more secondary outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

Instrument to be used: Software Neuro@home (semi immersive virtual reality system for neurological rehabilitation) was used. In each of the sessions, an avatar on screen that representing the patient was regulated by the patient to perform a virtual task that focused on the training of a specific body part. Programme schedule: Each session of virtual reality therapy lasted for thirty minutes. Day 0 included an orientation to the machine with five minutes of gaming. This was followed by virtual reality therapy for five days a week at the same time of the day for three consecutive weeks.

Other: Virtual Reality

Control Group

NO INTERVENTION

Virtual reality sessions were not provided.

Interventions

As described in Experimental arm description.

Intervention Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with myelopathy with neurological level of injury below C4.
  • Both traumatic and non-traumatic myelopathy.
  • Duration of illness less than 6 months.

You may not qualify if:

  • Severe orthopedic or medical impairment that interfered with sitting.
  • Upper limb muscle power \<3/5.
  • Cognitive or visual impairment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Mental Heath and Neurosciences

Bangalore, Karnataka, 560029, India

Location

MeSH Terms

Conditions

Spinal Cord Diseases

Condition Hierarchy (Ancestors)

Central Nervous System DiseasesNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective Cohort study involving cases with use of intervention. Matched control cohort subjects were selected using pre-specified matching criteria (for matching with interventional cohort) as comparison group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 20, 2018

First Posted

July 19, 2018

Study Start

February 1, 2018

Primary Completion

May 30, 2018

Study Completion

May 30, 2018

Last Updated

July 19, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations